Hepatocyte‐specific Selenoi deficiency predisposes mice to hepatic steatosis and obesity
The FASEB Journal · 2024
DOI: 10.1096/fj.202400575rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Xin Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing, China. Hauptthemen laut MEDLINE: Fatty Liver, Hepatocytes, Obesity, Selenoproteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), MOST | National Key Research and Development Program of China (NKPs), The 111 project from the Education Ministry of China.
Abstract (Originalsprache)
Selenoprotein I ( Selenoi ) is highly expressed in liver and plays a key role in lipid metabolism as a phosphatidylethanolamine (PE) synthase. However, the precise function of Selenoi in the liver remains elusive. In the study, we generated hepatocyte‐specific Selenoi conditional knockout (cKO) mice on a high‐fat diet to identify the physiological function of Selenoi . The cKO group exhibited a significant increase in body weight, with a 15.6% and 13.7% increase in fat accumulation in white adipose tissue (WAT) and the liver, respectively. Downregulation of the lipolysis‐related protein (p‐Hsl) and upregulation of the adipogenesis‐related protein (Fasn) were observed in the liver of cKO mice. The cKO group also showed decreased oxygen consumption (VO 2 ), carbon dioxide production (VCO 2 ), and energy expenditure ( p < .05). Moreover, various metabolites of the steroid hormone synthesis pathway were affected in the liver of cKO mice. A potential cascade of Selenoi ‐phosphatidylethanolamine‐steroid hormone synthesis might serve as a core mechanism that links hepatocyte‐specific Selenoi cKO to biochemical and molecular reactions. In conclusion, we revealed that Selenoi inhibits body fat accumulation and hepatic steatosis and elevates energy consumption; this protein could also be considered a therapeutic target for such related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing, China.
- College of Fisheries and Life Science, Dalian Ocean University, Dalian, Liaoning, China.
- College of Veterinary Medicine, China Agricultural University, Beijing, China.
ORCID-Profile: Jia-Qiang Huang
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- MOST | National Key Research and Development Program of China (NKPs)
- The 111 project from the Education Ministry of China
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Huang, X., Li, T., Yang, S. H., Zhu, K. D., Wang, L. S., Dong, Y. L., & Huang, J. Q. (2024). Hepatocyte‐specific Selenoi deficiency predisposes mice to hepatic steatosis and obesity. The FASEB Journal. https://doi.org/10.1096/fj.202400575rr
Vancouver
Huang X, Li T, Yang SH, Zhu KD, Wang LS, Dong YL, et al. Hepatocyte‐specific Selenoi deficiency predisposes mice to hepatic steatosis and obesity. The FASEB Journal. 2024. doi:10.1096/fj.202400575rr
BibTeX
@article{Huang2024,
author = {Huang, Xin and Li, Tong and Yang, Shi-Hui and Zhu, Kong-di and Wang, Lian-Shun and Dong, Yu-Lan and Huang, Jia-Qiang},
title = {Hepatocyte‐specific Selenoi deficiency predisposes mice to hepatic steatosis and obesity},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202400575rr}
}
EUVIMED